Blog

February 29, 2016April 24, 2018

Luxottica and Valentino Announce 10-year License Agreement

Milan (Italy)- Luxottica Group and the Valentino fashion house announced that they have signed a new and exclusive eyewear license agreement for the design, manufacture and worldwide distribution of Valentino eyewear.

The ten-year agreement will be effective from January 2017. The first collection presented under the agreement will be available on the market from the beginning of the same year.

For full press release, click HERE.

February 26, 2016April 24, 2018

Swarovski Crystals and Serpentine Accents

Roberto Cavalli maintains its contemporary allure, strength and demure in its newest 2016 collection. These latest sunglass models are designed to be reminiscent of the 1950s style and flare. RC972S, a gorgeous sunglass with a subtle cat eye shape, lenses cut slightly short to allow for the iconic Roberto Cavalli snake frosted in Swarovski crystals to slither up the temple eye wire edge. RCO966, an ophthalmic frame, is designed for a woman with classic elegant taste. Created in rich acetate, jewel detail encrusts the temples, with the iconic RC monogram hidden within the serpent trademark logo. Sultry!

www.marcolin.com

February 26, 2016April 24, 2018

Marchon Eyewear Renews Global Licensing Agreement with Lacoste

Melville, NY – Marchon Eyewear, Inc. is pleased to announce the renewal of its global licensing agreement with Lacoste, a leading urban lifestyle brand which exemplifies elegance and comfort. Originally signed in 2011, the long-term extension of the licensing agreement grants Marchon the rights to design, produce and distribute Lacoste-branded sun and ophthalmic collections.

The eyewear collections are sold in Lacoste flagship locations worldwide, leading retail stores and speciality optical retailers.

For full press release, click HERE.

February 25, 2016April 24, 2018

IRIS Acquires Three New Optometry Clinics in Alberta

Langley, BC — IRIS, The Visual Group announces the acquisition of the three Urban Optique locations in Calgary, Okotoks and Airdrie, Alberta.

“Following recent press releases about our new acquisition strategy, we are particularly thrilled to announce our new partnership with Dr. Russ Reisner and his incredible team of doctors and employees. The three Urban Optique locations will add tremendous value to the IRIS network and we look forward to announcing other acquisitions in Alberta in the near future. ” — Dr. Michael Chaiken, Vice-President, Business Development and Regulatory Affairs.

Founded in 2006 by Dr. Harvey Kuntz and Dr. Russ Reisner, this Uncle/Nephew team has grown Urban Optique to be one of the largest privately held Optometric practices in Western Canada, with three locations and a team of 10 Optometrists and over 30 staff.

Dr. Russ Reisner started his career after earning his degree in optometry in 2001 from the University of Indiana. Like IRIS, the Urban Optique team is fully committed to
providing the absolute best experience to their patients. We are happy to welcome them to the IRIS family.

February 24, 2016April 24, 2018

Alcon Expands Glaucoma Treatment Portfolio by Acquiring Transcend Medical

Alcon announced that it has entered into an agreement to acquire Transcend Medical, Inc., a privately-held, US-based company focused on developing minimally-invasive surgical devices to treat glaucoma.

Transcend Medical, Inc. has recently developed a micro-stent to treat mild to moderate glaucoma. The MIGS device is implanted just below the surface of the eye. It is designed to treat less severe glaucoma by enhancing part of the natural drainage pathways of the eye with minimal tissue disruption. This allows the excess fluid in the eye to drain with the goal of reducing intraocular pressure (IOP) levels.

“We expect the MIGS technology to be a great addition to our device pipeline and to establish Alcon’s presence in this new surgical category to treat glaucoma,” said Mike Ball, CEO of Alcon. “If approved, it will provide a less invasive means of lowering IOP than traditional invasive glaucoma surgery, with the goal of lowering the dependency of topical ocular medication. This acquisition also expands Alcon’s leadership in glaucoma and cataract treatment as part of our Surgical business.”